Related Experiment Video

Updated: Feb 3, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond

Simon Linder1, Henk G van der Poel2, Andries M Bergman3,4

  • 1Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Endocrine-Related Cancer
|November 2, 2018
PubMed

Insights

Enzalutamide treats advanced prostate cancer by targeting the androgen receptor. Research explores optimizing its use and developing new strategies for enzalutamide-resistant metastatic castration-resistant prostate cancer.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Androgen receptor (AR) signaling drives metastatic castration-resistant prostate cancer (mCRPC) growth.
  • Novel drugs like enzalutamide target AR, but survival benefits are limited.
  • Optimal sequencing and novel therapies are needed for advanced prostate cancer.

Purpose of the Study:

  • To review enzalutamide's clinical use in advanced prostate cancer.
  • To discuss translational research on enzalutamide response and resistance.
  • To highlight novel treatment strategies for enzalutamide-resistant mCRPC.

Main Methods:

  • Literature review of clinical trials and translational studies.
  • Analysis of enzalutamide's efficacy and resistance mechanisms.
  • Synthesis of emerging therapeutic approaches for mCRPC.

Main Results:

  • Enzalutamide is a key treatment for advanced prostate cancer.
  • Understanding AR pathway resistance is crucial for treatment efficacy.
  • Several novel strategies are emerging for resistant prostate cancer.

Conclusions:

  • Optimizing enzalutamide use and combination therapies is essential.
  • Further research into resistance mechanisms will guide future mCRPC treatments.
  • Novel therapeutic strategies show promise for improving outcomes in advanced prostate cancer.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
227
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K